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Cladonia uncialis is a lichen species with confirmed anti-
bacterial activity and whose genome has been recently 
sequenced, enabling first attempts in its functional char-
acterization. In this work, we investigated activity of the 
C. uncialis acetone extract (CUE) and usnic acid (UA) en-
antiomers against ten clinical microbial strains causing 
skin infections. The results showed that CUE, containing 
(–)-UA and squamatic acid, assayed at the same concen-
trations as UA, was noticeably more active than (–)-UA 
alone, in its pure form. The studied CUE displayed an 
activity that was comparable to that of (+)-UA observed 
for Staphylococcus epidermidis and Enterococcus faecium 
(18–24 mm zone of growth inhibition), but did not dis-
play any activity against fungal strains. The CUE dem-
onstrated low cytotoxicity against HaCaT cells, in com-
parison to UA enantiomers, which is important for its 
therapeutic use. Results of the antioxidant assay (DPPH) 
indicated low antioxidant activity (IC50>200 µg/mL) of 
CUE, while the total phenolic content was 70.36 mg Gal-
lic Acid Equivalent/g of the dry extract.
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INTRODUCTION
Lichen species produce a wide range of secondary 
metabolites to increase their survival fitness under ex-
treme conditions. Numerous studies had shown that li-
chen micro-ecosystems produce substances that demon-
strate  multidirectional biological activity and thus could 
be used in pharmacology (Lücking et al., 2016). About 
50% (Candan et  al., 2007) of all 19 000 lichen species 
known to date (Abdel-Hammed et al., 2016) contain an-
tibacterial substances that could be used against antibi-
otic-resistant bacterial strains in treatment of wounds, 
skin infections, and upper respiratory and gastrointestinal 
symptoms. The most known lichenic compound is usnic 
acid (UA), existing in two enantiomeric forms of which 
(+)-UA occurs more frequently (Cetin et al., 2008). Re-
sults of research carried out so far indicate a high an-
tibacterial activity of UA, mainly against Gram-positive 
strains (Galanty et al., 2019). Most of studies on antibac-
terial activity of UA were focused on its (+) enantiomer, 
which usually demonstrated an increased activity in com-
parison to its (–) form (Galanty et al., 2012). In addition 
to antibacterial properties, UA has also antioxidant, anti-
proliferative, antiprotozoal, larvicidal and insecticidal, an-
tifungal, antiviral, algicidal, anti-inflammatory, pain-reliev-
ing and antipyretic properties, as has been demonstrated 
by in vivo and in vitro studies (Alahmadi, 2017).
Cladonia uncialis L. Weber ex F.H. Wigg., (order Le-
canorales, family Cladoniaceae), is a fruticose lichen, 
growing on humus or sandy soil, mainly in pinewood 
forests, on moors, dunes or roadside. This species is 
found on all continents except Antarctica, especially 
in the Northern Hemisphere. In Poland, it is common 
throughout the country (Purvis et al., 1992; Wójciak, 
2007). C. uncialis is known for its biosynthesis of (–)-UA, 
hardly observed in other lichen species (Abdel-Hameed 
et al., 2016). Recently, the C. uncialis genome has been 
sequenced, which allowed for its functional genomic 
analysis (Bertrand et al., 2018a). A number of biologi-
cally active secondary metabolites have been character-
ized via a homology mapping approach (Bertrand et al., 
2018a; Bertrand et al., 2018b), including  the well-studied 
aromatic polyketides (Bertrand et al., 2019). Neverthe-
less, functional analysis of C. uncialis and other lichens 
involving heterologous expression or gene knockout ex-
periments is still challenging due to their slow rate of 
growth, obligated symbioses and other difficulties in es-
tablishing their cultures (Grube et al., 2014; Bertrand et 
al., 2019; Cimmino et al., 2019). What is more, differenc-
es in cultivation conditions have impact on the extract 
composition (Bjerke et al., 2005; Brisdelli et al., 2013; 
Studzińska-Sroka et al., 2015). Consequently, there is still 
a noticeable disproportion between known biosynthetic 
gene clusters and characterized secondary metabolites of 
C. uncialis and other lichens (Bertrand et al., 2018a). To 
date, the genome sequencing of C. uncialis has revealed 
(Bertrand et al., 2018a) presence of 48 biosynthetic gene 
clusters, including: type I and III polyketide synthases 
(PKS), nonribosomal peptide synthetases (NRPS), hy-
brid PKS-NRPS and a terpene synthase. The C. uncialis 
genome was proposed to include enzymes for grayanic 
acid, patulin and betaenone biosynthesis, and the latter 
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two were not found in other lichen species (Bertrand et 
al., 2018b). A recent genome mining study of other li-
chen species, Evernia prunastri and Pseudevernia furfuracea, 
reported 80 biosynthetic gene clusters in the first one 
and 51 in the latter (Calchera et al., 2019) that also in-
cluded  polyketide synthases, non-ribosomal peptide syn-
thetases and terpene synthases.
The thallus of C. uncialis contains (–)-UA, as well as 
squamatic and thamnolic acids (Purvis et al., 1992), but 
the biological activity of its extracts is almost unknown. 
The antibacterial activity of C. uncialis extracts has been 
proven for the first time  in our previous studies, in 
which we demonstrated a high activity of the C. uncia-
lis acetone extract (CUE) on methicillin-resistant Staphy-
lococcus aureus (MRSA) strains (Studzińska-Sroka et al., 
2015). These interesting findings, as well as previous 
information about antimicrobial activity of UA (Galanty 
et al., 2012; Alahmadi et al., 2017; Galanty et al., 2019), 
prompted us to expand the study on the activity of CUE 
against clinical pathogenic strains responsible for skin 
and wound infections, which demonstrate resistance to 
antibiotics. In our research we also compared the cyto-
toxic effect of the tested substances by employing in vitro 
studies with human keratinocyte cell cultures (HaCaT). 
Although the cytotoxic properties of (+)-UA on HaCaT 
cells were previously studied, the respective research in-
volving CUE and (–)-UA has not been conducted yet 
(Brisdelli et al., 2013). We determined the CUE composi-
tion using NMR and MS, while the quantity of (–)-UA 
in CUE was determined with HPLC. The content of 
polyphenols (TPC) was evaluated with the Folin-Ciocal-
teu (FC) analysis. The antioxidant activity of (–)-UA and 
CUE was also investigated.
MATERIALS AND METHODS
Plant material. The C. uncialis (L.) Weber ex F.H. 
Wigg. lichen was manually collected in September 2014 
in Jastrzębsko Stare, Poland, and authenticated by dr 
Daria Zarabska-Bożejewicz (The Institute for Agricul-
tural and Forest Environment of Polish Academy of 
Sciences in Poznan). A voucher specimen (ES 2014.007) 
has been deposited in the herbarium of the Department 
of Pharmacognosy at Poznan University of Medical Sci-
ences.
General. Acetone, dimethylsulphoxide (DMSO), 
methanol, sodium carbonate and HPLC grade: water, 
chloroform and methanol, were purchased from POCH, 
Gliwice, Poland; HPLC grade: 85% phosphoric acid, 
2,2-diphenyl-1-picrylhydrazyl (DPPH), and the reference 
compounds: gallic acid, vitamin C and BHA were from 
Sigma Aldrich, USA. Folin-Ciocalteu’s phenol reagent, 
was from Merck, Germany; Usnic acids: (–)-usnic acid 
and (+)-usnic acid came from the compounds’ collection 
of the Pharmacognosy Department (their identity, optical 
rotation and purity were assessed by: UV, 1H NMR, 13C 
NMR, MS, and polarimetric analysis).
Preparation of extracts. Air-dried and coarsely 
ground lichen thalli (19 g) were extracted four times 
with 200 mL of acetone (800 mL total) in a ultrasonic 
bath (Elmasonic S 180H, Elma, Germany) at 30-35 °C 
for 30 min. The extracts were filtered using Whatman 
filter paper No. 1 and then evaporated under reduced 
pressure at 35°C, yielding 201.4 mg of solid residue. 
Determination of the total phenolic content. TPC 
was determined using the Folin-Ciocalteu method de-
scribed by Gawron-Gzella and others (Gawron-Gzella et 
al., 2016), with modifications. Briefly, 0.1 mL of CUE 
dissolved in DMSO (10 mg/mL) was mixed with 7.4 mL 
of distilled water and with 0.5 mL of the Folin-Ciocalteu 
reagent. The mixture was shaken vigorously and 2.0 mL 
of 20% (w/v) sodium carbonate solution was added af-
ter 1 min. Next, the samples were incubated for 30 min 
in the dark, at room temperature. The absorbance was 
measured at 760 nm (UV/VIS Lambda 35 PerkinElmer). 
Total polyphenol concentration was calculated using gal-
lic acid (0.02–0.08 mg/10 mL of sample) as a standard 
for a calibration curve (y=0.1016x – 0.0029, R2=0.9993). 
Total concentration of phenolic compounds in the ex-
tract was expressed as mg of gallic acid equivalent/g of 
the dry extract. The values are expressed as the mean of 
six replications ± S.D.
Quantification of (–)-usnic acid in the extract. 
The quantity of (–)-UA in C. uncialis acetone extract 
(CUE) was examined by HPLC as described previously 
(Studzińska-Sroka et al., 2015), with water and 1% 0.1N 
H3PO4 (v/v) (A) and methanol (B), A:B 15:85 as the 
mobile phase. Detection was carried out with a PDA 
detector set at 250 nm. To prepare the stock solution, 
5.0 mg of (–)-UA was dissolved in 5.0 mL of chloro-
form. In order to obtain calibration curves, appropri-
ate volumes of the stock solution were transferred to 
volumetric flasks and diluted with the same solvent to 
give standard solutions of the following concentrations: 
1.0, 0.5, 0.25, 0.125, and 0.0625 mg/mL (y=963.73x – 
16.051; R2=0.9986). Each concentration was analysed 
in triplicate under conditions described above. In order 
to analyse the samples, 5.0 mg of the tested extract was 
dissolved in 5.0 mL of chloroform. The results were re-
ported as the arithmetic mean ± S.D. for three replica-
tions.
NMR and MS analyses of the crude extract. Iden-
tification of main compounds in CUE was carried out 
by NMR (700 MHz NMR spectrometer Bruker Avance 
III). Spectra were recorded after dissolving the substance 
in acetone-d6 and over TMS. ESI-MS data were acquired 
with Waters Maldi Q-Tof Premier mass spectrometer. 
Determination of antibacterial activity. In this 
study, strains mostly responsible for skin infections were 
employed: clinical strains of Gram-positive bacteria - 
staphylococci (Staphylococcus aureus, Staphylococcus epidermidis 
and Staphylococcus haemolyticcus), enterococci (Enterococcus 
faecalis and Enterococcus faecium), streptococci (Streptococcus 
pyogenes), Gram-negative bacilli (Escherichia coli and Pseu-
domonas aeruginosa), and yeast-like fungi (Candida albicans 
and Candida glabrata). The isolated strains were tested for 
their antibiotic sensitivity and the following culture me-
dia were used: Mueller Hinton Agar (OXOID), Mueller 
Hinton Agar with horse blood (OXOID) for bacterial 
strains, and RPMI agar (BioMaxima) for yeast-like fungi. 
Disc diffusion method was used to determine the antimi-
crobial activity, and therefore the results were expressed 
as the diameter of the zone of growth inhibition  of the 
tested microorganisms by the tested substances. For the 
antimicrobial study, solutions of the acetone extract, as 
well as (–)-UA and (+)-UA in DMSO, were prepared 
(10 mg/mL). Blank sterile discs (Ø=6 mm; OXOID) 
were placed with slight pressure on inoculated media and 
impregnated with 10 μL of the tested substances to ob-
tain a content of 100 μg of the extract or usnic acids in 
the disc. The Petri Dishes were incubated for 24 h for 
bacteria and 48 h for fungi, and the zone of inhibition 
was measured. Standard antibiotics’ dishes for the test-
ed microorganisms for Gram-positive bacteria (penicil-
lin, amoxicillin/clavulanic acid, vancomycin, erythromy-
cin, and clindamycin), to compare the inhibition zones 
around the antibiotic disc, were used as positive con-
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trols. DMSO solution was used as the negative control 
of the influence of the solvents. The inoculum density 
of 0.5 on McFarland scale was used for the disk diffu-
sion method. All of the experiments were performed in 
triplicates and the antibacterial activity was expressed as 
the mean values.
Viability assay. Spontaneously immortalized HaCaT 
keratinocytes (Cell Lines Service, Germany) were grown 
in a high-glucose DMEM medium (Biowest, France), 
supplemented with 10% FBS (EURx, Poland), and 1% 
antibiotics solution (penicillin and streptomycin, Biowest, 
France), in a humidified incubator in the atmosphere of 
5% CO2. Stock solutions of the dry extract, (–)-UA and 
(+)-UA samples were prepared in DMSO. The effect 
of the solutions on the viability of HaCaT cells was as-
sessed by using the MTT assay. Cells were seeded (2×104 
cells/well) in a 96-well plate and preincubated for ~24 h. 
Next, fresh medium containing varying concentrations of 
the tested substances (1–50 μg/mL) was added into the 
wells and the cells were incubated for subsequent 72 h. 
Afterwards, the cells were washed with PBS buffer and a 
fresh complete medium containing 0.5 mg/mL of MTT 
salt (Sigma, USA) was added. After a 4-hour incuba-
tion, formazan crystals were dissolved in acidic isopro-
panol and the absorbance was measured at 570 nm and 
690 nm. The assay was repeated three times with five 
measurements per assay. The results were calculated as 
percentage viability compared to control cells only treat-
ed with the vehicle. 
DPPH assay. The free radical scavenging capacity of 
the acetone extract from C. uncialis was determined us-
ing the DPPH method described by Annegowda et al. 
(2010). Briefly, 0.1 mL of CUE, (–)-UA or (+)-UA, dis-
solved in DMSO (6.0–0.1875 mg/mL) was added to 2.9 
mL of DPPH solution (0.1 mM in methanol; the final 
assay concentrations were 200.0–6.25 µg/mL). The reac-
tion mixture was shaken and incubated in the dark at 
room temperature for 30 min. Absorbance was meas-
ured at 517 nm against a blank (2.9 mL of methanol + 
0.1 mL of DMSO) (UV/VIS Lambda 35 PerkinElmer). 
The control was a mixture of 2.9 mL of DPPH solution 
and 0.1 mL of DMSO. Vitamin C and BHA were used 
as the referring substances. The following equation was 
used to calculate concentration of the DPPH radicals:
DPPH scavenging activity (%)=(A0–A1)/A0×100%
where A0 is the absorbance of the control and A1 is the 
absorbance of the reaction mixture or standards. The 
IC50 values were calculated as the concentration required 
to inhibit 50% of DPPH radical. The values have been 
expressed as the mean of six replications.
Homology modelling of C. uncialis polyketide synthase. 
A homology model of C. uncialis non-reducing polyketide 
synthase was constructed using the C. nicotianae crystal 
structure (Herbst et al., 2018) (PDB id: 6FIJ), compris-
ing of three domains: SAT, KS and MAT. This template, 
of the highest sequence overlap with the target, was se-
lected by BLAST (Madden et al., 1996) from PDB (E-
value equal to 3e-104, sequence identity 26.53% and se-
quence coverage 46%). Only the KS domain model of 
the polyketide synthase (Fig. 1) was constructed using 
the BLAST-derived sequence alignment, MODELLER 
(Webb et al., 2016), and a previously developed proce-
dure (Latek, 2017). 
Statistical analysis. Statistical analyses were per-
formed using GraphPad Prism version 5.00 for Windows 
(GraphPad Software, San Diego, CA) and Microsoft Ex-
cel 2013 software (Microsoft, Redmond, WA). The me-
dian effect concentrations (IC50 values) were determined 
using a concentration-response curve. 
RESULTS AND DISCUSSION
Phytochemical characterisation of the extract
Chemical composition of CUE (201.4 mg, yield 
1.06%), examined by 1H NMR and MS, confirmed that 
its main compounds were UA and squamatic acid (re-
sult presented in Fig. 2). Presence of thamnolic acid de-
scribed in the C. uncialis thallus was not confirmed with 
sufficient certainty using the applied procedure. The 
content of (–)-UA (52.52%±0.28),  in the extract ana-
lysed by HPLC, was higher than in our previous study 
(28.40%) (Studzińśka-Sroka et al., 2015). This difference, 
as well as the lack of thamnolic acid in the studied ex-
tract, could result from various atmospheric conditions 
during the vegetation period of the lichen (Bjerke et al., 
2005; Millot el al., 2007; Neupane et al., 2017). The re-
sults of FC analysis showed TPC equal to 70.36 ± 1.42 
mg GAE/g of the dry extract, which is in accordance 
with data on TPC in other Cladonia species (Mitrović  et 
al., 2011).
Antimicrobial activity
The emerging problem of bacterial resistance to ex-
isting antibiotics prompted research of new antibacterial 
agents that were derived from natural substances. Our 
study was aimed at evaluating the antimicrobial activ-
ity of CUE and UA enantiomers against eight clinical 
bacterial and two fungal strains, mainly responsible for 
skin infections and post-operative wounds. The obtained 
results demonstrated an increased activity of the tested 
substances against selected Gram-positive microorgan-
isms, with no impact on Gram-negative strains (Table 1). 
The highest growth inhibitory zone (GIZ) was obtained 
for coagulase-negative staphylococci (CNS) (S. epidermidis, 
S. haemolyticus) and enterococci (E. faecalis, E. faecium). S. 
aureus and S. pyogenes were also affected, but to a lesser 
extent. In the case of enterococci and CNS (S. epidermidis, 
S. haemolyticus), GIZ was almost the same between (+)-
UA and CUE, but smaller for (–)-UA. For S. aureus, no 
Figure 1. The central KS domain of the loading/condensing re-
gion (SAT-KS-MAT) of C. uncialis polyketide synthase. 
The active site is depicted with Cys547 shown with spheres and 
other residues are shown with a balls and sticks representation.
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major differences between the test-
ed substances were, observed. For 
S. pyogenes,  GIZ for (+)-UA was 
the smallest.
It is widely known that thera-
peutic effect of chiral drugs may 
differ for the particular enantiom-
ers (McConathy et al., 2003). Our 
results show that (+)-UA demon-
strated the highest antibacterial ac-
tivity against 5 out of 6 examined 
strains of Gram-positive bacteria, 
while (–)-UA acted more strongly 
only on S. pyogenes. The mechanism 
of antibacterial action of usnic acid 
was previously described. Namely, 
UA induces inhibition of RNA and 
DNA synthesis in Gram-positive 
bacteria (Bacillus subtilis and S. au-
reus), while in E. coli it does not in-
hibit production of any macromol-
ecules (DNA, RNA, and proteins) 
(Maciąg-Dorszyńska et al., 2014). 
This may explain the effect of the 
extract and usnic acid on the in-
dividual microbial strains involved 
in this study. Interestingly, our re-
sults showed that CUE, containing 
52.52% of (–)-UA, demonstrated 
a higher activity in comparison to 
pure (–)-UA used at the same con-
centration. In our previous study, 
we observed that squamatic acid, 
Figure 2. 1H NMR and MS analysis of Cladonia uncialis acetone extract. 
(A) 1H NMR (700 MHz, acetone-d6) of Cladonia uncialis crude extract and formulas of the two main components. (B) 1H NMR (700 MHz, 
acetone-d6) of Cladonia uncialis crude extract. (C) MS of Cladonia uncialis crude extract. Note: UA, usnic acid; SA, squamatic acid; (D) 1H 
NMR (700 MHz) and MS data for Cladonia uncialis crude extract metabolites.
Table 1. Zone of growth inhibition for (+)–, (–)–usnic acids and the acetone extract of 
C. uncialis against bacteria and yeast–like fungi strains isolated from patients. 
Clinical strains
Zone of growth inhibition (mm)
(+)–UA (–)–UA CUE V P AmC E Cl
Staphylococcus  
aureus 10   9 10 19 11 28 27 28
Staphylococcus  
epidermidis 23 20 23 18 – 22 30 27
Staphylococcus  
haemolyticus 22 12 22 17 – – – –
Enterococcus  
faecalis 21 15 21 17 – 28 – –
Enterococcus  
faecium 24 18 24 21 – – – –
Streptococcus  
pyogenes   9 12 12 18 28 34 23 20
Escherichia  
coli – – – – – – – –
Pseudomonas  
aeruginosa – – – – – – – –
Candida  
albicans – – – – – – – –
Candida  
glabrata – – – – – – – –
Note: (+)–UA, (+)–Usnic acid 100 µg/disc; (–)–UA, (–)–Usnic acid 100 µg/disc; CUE, C. uncialis ac-
etone extract – 100 µg/disc; AmC, Amoxicillin/Clavulanic acid 30 µg/disc; Cl, Clindamycin 2 µg/
disc; E, Erythromycin 15 µg/disc; P, Penicillin 1 µg/disc; V, Vancomycin 30 µg/disc; „–„not active 
= no inhibition zone = disc diameter. The results were reported as the arithmetic mean obtained 
from 3 measurements.
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present in CUE, had no antibacterial effect against S. au-
reus (Studzińska-Sroka et al., 2015), while thamnolic acid, 
whose presence in this specie was described in the litera-
ture, demonstrated only a very weak activity: MIC 200–
400 µg/mL, for Gram-positive and  Gram-negative bac-
teria, yeasts and filamentous fungi (Cankılıç et al., 2017). 
Based on the above, we suppose that the extract should 
contain low quantities of other, unidentified compounds 
that were responsible for its antibacterial activity and/
or the specific synergism of its action. In this study, we 
observed a high effectiveness of CUE against Gram-pos-
itive bacteria: S. haemolyticus, E. faecalis and E. faecium that 
are known for their resistance to commonly used anti-
bacterial drugs (Amyes et al., 2007; Fredheim et al., 2009). 
In this context, our results for the tested lichen-derived 
substances, especially CUE, may have future therapeutic 
applications as antibacterial agents for antibiotic-resistant 
strains. Lack of the antifungal activity of the lichen ex-
tract and its compounds has often been described (Yang 
et al., 1999).
Cell viability
Keratinocytes (HaCaT) are a good in vitro model of 
epidermis. Other studies indicated that (+)-UA had 
a strong cytotoxic activity against keratinocytes (EC50 
35 µM and 75 µM, in crystal violet or neutral red uptake 
assays, respectively) (Burlando et al., 2009). Our results 
show that (+)-UA was more cytotoxic in comparison to 
(–)-UA and CUE (at a concentration of 5 µg/mL, the vi-
ability of HaCaT cells was: 88.3%, 61.4%, and 46.9% for 
CUE, (–)-UA and (+)-UA, respectively) and this effect 
was dose-dependent (Fig. 3). Differences in cytotoxicity 
among enantiomers of UA have been already described 
in the literature (Galanty et al., 2019), but numerous 
studies questioned using cancer cell lines for this pur-
pose. Namely, it was shown that  the cancer cells were 
usually more sensitive to (–)-UA (L1210, Du145, K562, 
breast cancer, Capan-2, breast adenocarcinoma) (Bazin et 
al., 2008; Einarsdóttir et al., 2010; Ebrahim et al., 2017), 
whereas (+)-UA was usually more toxic to V79, A549 
(Koparal et al., 2006). Keratinocyte cells 
(HaCaT) were supposed to be a more 
standard biological system for testing 
CUE cytotoxicity but there has been 
no experimental data confirming this 
hypothesis and, to our knowledge, our 
study is the first one to demonstrate this. 
Our results indicate the safety of using 
CUE as an antibacterial agent and sug-
gest that using it in antimicrobial oint-
ments could be beneficial. 
Antioxidant activity
So far, no studies have been published 
on the antioxidant activity of C. uncialis 
and (–)-UA. The results of our DPPH 
analysis showed that CUE, (–)-UA and 
(+)-UA had low antioxidant activity 
(IC50> 200 µg/mL; at 200 µg/mL the 
ability to scavenge DPPH was 9.8%, 
13.2% and 14.0% for CUE, (–)-UA and 
(+)-UA, respectively). The observed low 
antioxidant activity of (+)-UA is consist-
ent with previous data (IC50=691 µg/
mL) described by Ananthi and others 
(Ananthi et al., 2015). Moreover, Brisdelli 
and others (Brisdelli et al., 2013) demon-
strated that usnic acid at the concentra-
tion of 0.8 mM, did not show a signifi-
cant ability to reduce  concentration of 
the DPPH radical. Taking into account 
results of the above research, it can be 
assumed that the low antioxidant activity 
of CUE shown in our DPPH analysis, 
is probably due to a significant UA con-
tent. Despite the poor ability to scavenge 
the DPPH radical, UA displayed antioxi-
Figure 3. The effect of lichen-derived substances on the viability 
of HaCaT cells. 
Mean values ± S.E.M. obtained from three independent experi-
ments are shown.
Figure 4. Comparison of C. uncialis (A and C) and C. nicotianae (B and D) active 
sites in KS domains. 
Active site residues are shown with the ball and sticks representation, and Cys547 
is depicted with the sphere representation. Water molecules present in the crystal 
structure of C. nicotianae polyketide synthase are shown as blue spheres when situ-
ated close to Cys547, and blue crosses when situated at a distance from this residue. 
There is an explicit water flow through the binding site tunnel in the C. nicotianae 
crystal structure of KS that could be produced, e.g., in the esterification reaction be-
tween the polyketide starter carboxyl group and SH of Cys547. The active site tunnel 
is similar in both homologous synthases, but Cys547 (yellow surface) is more visible 
in case of the C. uncialis synthase.
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dant properties in other research models (in vivo, in vitro). 
For example, UA isolated from Usnea longissima demon-
strated an antioxidant effect and also increased the level 
of antioxidant enzymes in rats (Odabasoglu et al., 2006). 
Kohlhardt-Floehr  and others (Kohlhardt-Floehr et al., 
2010) had shown that under physiological conditions, 
low concentrations of UA extracted from Xanthoparmelia 
farinosa demonstrated antioxidant properties. Neverthe-
less, the above results suggest that the tested CUE may 
demonstrate antiradical properties.
Molecular description of the KS domain of non-
reducing polyketide synthase
C. uncialis methylphloroacetophenone synthase (MPAS), 
like other polyketide synthases (PKS) (Herbst et al., 2018), 
is a microbial multidomain enzyme that catalyses polyke-
tide biosynthesis in various species. The first step of pol-
yketide synthesis involves loading/condensing a substrate 
onto an integral acyl carrier protein (ACP) and then trans-
ferring it to the ketosynthase (KS) domain interacting with 
the starter unit acyltransferase (SAT) and malonyl-CoA-
specific acyltransferase (MAT) domains. Other domains of 
C. uncialis MPAS (Uniprot entry: A0A0R8YWJ7) include 
the methyltransferase (CMeT) and Claisen cyclase (CLC) 
domains. Polyketide synthesis begins at the binding site of 
KS domain with a conserved Cys547 residue (see Fig. 4). 
The active site tunnel of C. uncialis KS is similar to the 
active site of Cercospora nicotianae KS, for which the SAT-
KS-MAT complex structure is available in PDB (Herbst 
et al., 2018). There is, however, a difference in one active 
site residue (Thr instead of Cys) that is close to the ac-
tive site Cys547 (see Fig. 4). The first stage of the pol-
yketide synthesis involves forming a thioester between 
the carboxyl group of the polyketide starter and SH of 
Cys547, and further elongation of the polyketide chain 
(MAT domain) and cyclization (CLC domain) (Herbst et 
al., 2018). The resulting intermediate product of MPAS is 
methylphloracetophenone that subsequently undergoes 
oxidative dimerization to usnic acid which is carried out 
by the methylphloracetophenone oxidase (MPAO) (Abdel-
Hameed et al., 2016).
CONCLUSIONS
Based on the results of microbiological tests, the ac-
etone extract from C. uncialis may be considered as a 
source of interesting lichen substance, helpful in treatment 
of skin infections caused by antibiotic-resistant bacterial 
strains. It should be emphasized that CUE is less toxic 
and at the same time its antibacterial activity is stronger 
than pure (+)-UA, used, e.g. as an antibacterial agent in 
topical formulations (Bruno et al., 2013; Francolini et al., 
2018). The biosynthesis potential of C. uncialis and other 
lichens is still poorly explored due to the lack of any ex-
perimental evidence for definite linking biosynthetic gene 
clusters with secondary metabolites. Only recently, first 
attempts in the functional genome annotation have been 
carried out (Bertrand et al., 2018a; Calchera et al., 2019). 
Nevertheless, their importance as a natural source of pol-
yketides from which a number of pharmacologically active 
substances is derived (Helfrich et al., 2014), would increase 
the intensity of ongoing research.
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